Listed

Atea Pharmaceuticals, Inc.

AVIRNasdaqCIK 1593899HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$35.1m, Q2 FY2026
Net income−$32.9m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m28.2Research and development, Q3 FY2023, three months to 2023-09-30$28.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-123447.Report this figure35.0Research and development, Q4 FY2023, three months to 2023-12-31$35.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-06, accession 0000950170-25-034808. Derived: 12-month figure less the 9-month figure.Report this figure57.6Research and development, Q1 FY2024, three months to 2024-03-31$57.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0000950170-25-069367.Report this figure34.7Research and development, Q2 FY2024, three months to 2024-06-30$34.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105123.Report this figure26.2Research and development, Q3 FY2024, three months to 2024-09-30$26.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figure25.7Research and development, Q4 FY2024, three months to 2024-12-31$25.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001193125-26-094159. Derived: 12-month figure less the 9-month figure.Report this figure29.6Research and development, Q1 FY2025, three months to 2025-03-31$29.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219678.Report this figure32.3Research and development, Q2 FY2025, three months to 2025-06-30$32.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure38.3Research and development, Q3 FY2025, three months to 2025-09-30$38.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figure47.8Research and development, Q4 FY2025, three months to 2025-12-31$47.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001193125-26-094159. Derived: 12-month figure less the 9-month figure.Report this figure41.1Research and development, Q1 FY2026, three months to 2026-03-31$41.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219678.Report this figure28.2Research and development, Q2 FY2026, three months to 2026-06-30$28.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure
Operating income$m(40.8)Operating income, Q3 FY2023, three months to 2023-09-30−$40.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123447.Report this figure(46.6)Operating income, Q4 FY2023, three months to 2023-12-31−$46.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-06, accession 0000950170-25-034808. Derived: 12-month figure less the 9-month figure.Report this figure(69.8)Operating income, Q1 FY2024, three months to 2024-03-31−$69.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0000950170-25-069367.Report this figure(46.9)Operating income, Q2 FY2024, three months to 2024-06-30−$46.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105123.Report this figure(37.2)Operating income, Q3 FY2024, three months to 2024-09-30−$37.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figure(39.0)Operating income, Q4 FY2024, three months to 2024-12-31−$39.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-094159. Derived: 12-month figure less the 9-month figure.Report this figure(39.0)Operating income, Q1 FY2025, three months to 2025-03-31−$39.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219678.Report this figure(41.3)Operating income, Q2 FY2025, three months to 2025-06-30−$41.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure(45.6)Operating income, Q3 FY2025, three months to 2025-09-30−$45.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figure(54.9)Operating income, Q4 FY2025, three months to 2025-12-31−$54.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-094159. Derived: 12-month figure less the 9-month figure.Report this figure(48.0)Operating income, Q1 FY2026, three months to 2026-03-31−$48.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219678.Report this figure(35.1)Operating income, Q2 FY2026, three months to 2026-06-30−$35.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure
Income tax$m0.2Income tax, Q3 FY2023, three months to 2023-09-30$221.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0000950170-24-123447.Report this figure0.3Income tax, Q4 FY2023, three months to 2023-12-31$349.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-06, accession 0000950170-25-034808. Derived: 12-month figure less the 9-month figure.Report this figure0.2Income tax, Q1 FY2024, three months to 2024-03-31$231.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-12, accession 0000950170-25-069367.Report this figure0.2Income tax, Q2 FY2024, three months to 2024-06-30$243.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0000950170-25-105123.Report this figure0.2Income tax, Q3 FY2024, three months to 2024-09-30$226.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figure0.2Income tax, Q4 FY2024, three months to 2024-12-31$225.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-05, accession 0001193125-26-094159. Derived: 12-month figure less the 9-month figure.Report this figure0.2Income tax, Q1 FY2025, three months to 2025-03-31$203.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001193125-26-219678.Report this figure0.2Income tax, Q2 FY2025, three months to 2025-06-30$207.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure0.2Income tax, Q3 FY2025, three months to 2025-09-30$196.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figure(6.8)Income tax, Q4 FY2025, three months to 2025-12-31−$6.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-05, accession 0001193125-26-094159. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2026, three months to 2026-03-31$50.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001193125-26-219678.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$24.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure
Net income$m(33.1)Net income, Q3 FY2023, three months to 2023-09-30−$33.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123447.Report this figure(39.2)Net income, Q4 FY2023, three months to 2023-12-31−$39.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-06, accession 0000950170-25-034808. Derived: 12-month figure less the 9-month figure.Report this figure(63.2)Net income, Q1 FY2024, three months to 2024-03-31−$63.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figure(40.5)Net income, Q2 FY2024, three months to 2024-06-30−$40.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figure(31.2)Net income, Q3 FY2024, three months to 2024-09-30−$31.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figure(33.5)Net income, Q4 FY2024, three months to 2024-12-31−$33.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-094159. Derived: 12-month figure less the 9-month figure.Report this figure(34.3)Net income, Q1 FY2025, three months to 2025-03-31−$34.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure(37.2)Net income, Q2 FY2025, three months to 2025-06-30−$37.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure(42.0)Net income, Q3 FY2025, three months to 2025-09-30−$42.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figure(44.9)Net income, Q4 FY2025, three months to 2025-12-31−$44.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-094159. Derived: 12-month figure less the 9-month figure.Report this figure(45.4)Net income, Q1 FY2026, three months to 2026-03-31−$45.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure(32.9)Net income, Q2 FY2026, three months to 2026-06-30−$32.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure
Diluted EPS$ per share(0.40)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-123447.Report this figurenot reported(0.75)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.75 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0000950170-25-069367.Report this figure(0.48)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-105123.Report this figure(0.37)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figurenot reported(0.40)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219678.Report this figure(0.44)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure(0.53)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.53 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figurenot reported(0.57)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.57 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219678.Report this figure(0.41)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure
Basic EPS$ per share(0.40)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-123447.Report this figurenot reported(0.75)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.75 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0000950170-25-069367.Report this figure(0.48)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-105123.Report this figure(0.37)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figurenot reported(0.40)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219678.Report this figure(0.44)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.44 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure(0.53)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.53 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figurenot reported(0.57)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.57 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219678.Report this figure(0.41)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure

Balance sheet

Cash and equivalents$76.5m, Q2 FY2026
Shareholders' equity$204.2m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m138Cash and equivalents, Q3 FY2023, at 2023-09-30$137.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-08, accession 0000950170-23-061213.Report this figure144Cash and equivalents, FY2023, at 2023-12-31$143.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-06, accession 0000950170-25-034808.Report this figure161Cash and equivalents, Q1 FY2024, at 2024-03-31$160.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0000950170-24-059699.Report this figure243Cash and equivalents, Q2 FY2024, at 2024-06-30$243.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-07, accession 0000950170-24-092914.Report this figure98.5Cash and equivalents, Q3 FY2024, at 2024-09-30$98.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-123447.Report this figure64.7Cash and equivalents, FY2024, at 2024-12-31$64.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-05, accession 0001193125-26-094159.Report this figure119Cash and equivalents, Q1 FY2025, at 2025-03-31$119.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0000950170-25-069367.Report this figure87.7Cash and equivalents, Q2 FY2025, at 2025-06-30$87.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-105123.Report this figure77.3Cash and equivalents, Q3 FY2025, at 2025-09-30$77.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figure95.7Cash and equivalents, FY2025, at 2025-12-31$95.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure79.3Cash and equivalents, Q1 FY2026, at 2026-03-31$79.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-219678.Report this figure76.5Cash and equivalents, Q2 FY2026, at 2026-06-30$76.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure
Current assets$m603Current assets, Q3 FY2023, at 2023-09-30$603.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061213.Report this figure590Current assets, FY2023, at 2023-12-31$590.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-06, accession 0000950170-25-034808.Report this figure549Current assets, Q1 FY2024, at 2024-03-31$548.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059699.Report this figure506Current assets, Q2 FY2024, at 2024-06-30$506.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-07, accession 0000950170-24-092914.Report this figure487Current assets, Q3 FY2024, at 2024-09-30$486.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123447.Report this figure462Current assets, FY2024, at 2024-12-31$462.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-05, accession 0001193125-26-094159.Report this figure434Current assets, Q1 FY2025, at 2025-03-31$433.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0000950170-25-069367.Report this figure386Current assets, Q2 FY2025, at 2025-06-30$385.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105123.Report this figure336Current assets, Q3 FY2025, at 2025-09-30$336.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figure311Current assets, FY2025, at 2025-12-31$311.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure263Current assets, Q1 FY2026, at 2026-03-31$263.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219678.Report this figure229Current assets, Q2 FY2026, at 2026-06-30$228.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure
Total assets$m608Total assets, Q3 FY2023, at 2023-09-30$608.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0000950170-23-061213.Report this figure595Total assets, FY2023, at 2023-12-31$595.0m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-06, accession 0000950170-25-034808.Report this figure553Total assets, Q1 FY2024, at 2024-03-31$553.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0000950170-24-059699.Report this figure510Total assets, Q2 FY2024, at 2024-06-30$510.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0000950170-24-092914.Report this figure491Total assets, Q3 FY2024, at 2024-09-30$491.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-123447.Report this figure465Total assets, FY2024, at 2024-12-31$464.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-05, accession 0001193125-26-094159.Report this figure440Total assets, Q1 FY2025, at 2025-03-31$440.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0000950170-25-069367.Report this figure392Total assets, Q2 FY2025, at 2025-06-30$391.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-105123.Report this figure343Total assets, Q3 FY2025, at 2025-09-30$343.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figure315Total assets, FY2025, at 2025-12-31$315.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure267Total assets, Q1 FY2026, at 2026-03-31$267.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001193125-26-219678.Report this figure232Total assets, Q2 FY2026, at 2026-06-30$232.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure
Current liabilities$m18.9Current liabilities, Q3 FY2023, at 2023-09-30$18.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061213.Report this figure32.4Current liabilities, FY2023, at 2023-12-31$32.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-06, accession 0000950170-25-034808.Report this figure41.3Current liabilities, Q1 FY2024, at 2024-03-31$41.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059699.Report this figure26.6Current liabilities, Q2 FY2024, at 2024-06-30$26.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-07, accession 0000950170-24-092914.Report this figure25.2Current liabilities, Q3 FY2024, at 2024-09-30$25.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123447.Report this figure18.6Current liabilities, FY2024, at 2024-12-31$18.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-05, accession 0001193125-26-094159.Report this figure21.7Current liabilities, Q1 FY2025, at 2025-03-31$21.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0000950170-25-069367.Report this figure20.1Current liabilities, Q2 FY2025, at 2025-06-30$20.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105123.Report this figure20.2Current liabilities, Q3 FY2025, at 2025-09-30$20.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figure39.8Current liabilities, FY2025, at 2025-12-31$39.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure33.4Current liabilities, Q1 FY2026, at 2026-03-31$33.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219678.Report this figure28.1Current liabilities, Q2 FY2026, at 2026-06-30$28.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure
Total liabilities$m26.3Total liabilities, Q3 FY2023, at 2023-09-30$26.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0000950170-23-061213.Report this figure39.8Total liabilities, FY2023, at 2023-12-31$39.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-06, accession 0000950170-25-034808.Report this figure48.7Total liabilities, Q1 FY2024, at 2024-03-31$48.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0000950170-24-059699.Report this figure33.9Total liabilities, Q2 FY2024, at 2024-06-30$33.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-07, accession 0000950170-24-092914.Report this figure32.4Total liabilities, Q3 FY2024, at 2024-09-30$32.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-123447.Report this figure25.8Total liabilities, FY2024, at 2024-12-31$25.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-05, accession 0001193125-26-094159.Report this figure28.9Total liabilities, Q1 FY2025, at 2025-03-31$28.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0000950170-25-069367.Report this figure27.2Total liabilities, Q2 FY2025, at 2025-06-30$27.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-105123.Report this figure27.2Total liabilities, Q3 FY2025, at 2025-09-30$27.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figure39.8Total liabilities, FY2025, at 2025-12-31$39.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-05, accession 0001193125-26-094159.Report this figurenot reportednot reported
Shareholders' equity$m582Shareholders' equity, Q3 FY2023, at 2023-09-30$581.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-123447.Report this figure555Shareholders' equity, FY2023, at 2023-12-31$555.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-05, accession 0001193125-26-094159.Report this figure504Shareholders' equity, Q1 FY2024, at 2024-03-31$504.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figure476Shareholders' equity, Q2 FY2024, at 2024-06-30$476.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figure459Shareholders' equity, Q3 FY2024, at 2024-09-30$458.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figure439Shareholders' equity, FY2024, at 2024-12-31$438.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure411Shareholders' equity, Q1 FY2025, at 2025-03-31$411.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure364Shareholders' equity, Q2 FY2025, at 2025-06-30$364.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure316Shareholders' equity, Q3 FY2025, at 2025-09-30$315.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figure275Shareholders' equity, FY2025, at 2025-12-31$275.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure234Shareholders' equity, Q1 FY2026, at 2026-03-31$233.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure204Shareholders' equity, Q2 FY2026, at 2026-06-30$204.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure

Cash flow

Operating cash flow−$37.1m, Q2 FY2026
Share repurchases$0, Q4 FY2025
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(17.6)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$17.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-123447. Derived: 9-month figure less the 6-month figure.Report this figure(21.8)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$21.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-06, accession 0000950170-25-034808. Derived: 12-month figure less the 9-month figure.Report this figure(39.9)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$39.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0000950170-25-069367.Report this figure(42.2)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$42.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-105123. Derived: 6-month figure less the 3-month figure.Report this figure(23.0)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$23.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-277815. Derived: 9-month figure less the 6-month figure.Report this figure(30.4)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$30.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001193125-26-094159. Derived: 12-month figure less the 9-month figure.Report this figure(30.6)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$30.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219678.Report this figure(32.9)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$32.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-347021. Derived: 6-month figure less the 3-month figure.Report this figure(40.4)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$40.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-277815. Derived: 9-month figure less the 6-month figure.Report this figure(28.2)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$28.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001193125-26-094159. Derived: 12-month figure less the 9-month figure.Report this figure(46.4)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$46.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219678.Report this figure(37.1)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$37.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-347021. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported11.4Share repurchases, Q3 FY2025, three months to 2025-09-30$11.4m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-12, accession 0001193125-25-277815. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-03-05, accession 0001193125-26-094159. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)80.05m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares83.3Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3083,258,537 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0000950170-23-061213.Report this figure83.3Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3183,332,397 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0000950170-24-059699.Report this figure83.4Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3083,399,377 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-07, accession 0000950170-24-092914.Report this figure83.4Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3083,399,769 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-123447.Report this figure83.9Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3183,916,193 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0000950170-25-069367.Report this figure84.3Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3084,253,700 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-105123.Report this figure84.4Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3084,422,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figure85.2Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3185,159,254 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-219678.Report this figure83.7Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3083,747,335 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure79.1Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3079,052,154 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-277815.Report this figure79.2Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3179,198,204 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-219678.Report this figure80.1Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3080,050,518 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure

Shares outstanding: 80.20mShares outstanding, period not labelled, at 2026-08-1080,204,699 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-347021.Report this figure at Aug 10, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. Listed shows no prices and gives no investment advice.